Bret Christensen net worth and biography

Bret Christensen Biography and Net Worth

EVP of Insulet

Mr. Christensen has served as our Executive Vice President and Chief Commercial Officer since February 2019. Prior, he served as our Senior Vice President and Chief Commercial Officer since May 2017. He brings more than 20 years of commercial experience to Insulet. Mr. Christensen joins the Company from Myriad Genetics, where he served as General Manager of Preventive Care, the company's largest business unit, leading a team of more than 350 employees across all commercial functions. Prior to Myriad Genetics, Mr. Christensen held a series of executive positions at Hologic Corporation, including Vice President of Sales and Marketing of its Gynecologic Surgical Products division. Prior to Hologic, he led key market development and sales teams at Cytyc Corporation. Mr. Christensen earned a B.S. in Business Management from Utah Valley University and received an MBA from the University of Utah.

What is Bret Christensen's net worth?: The estimated net worth of Bret Christensen is at least $5.21 million as of August 24th, 2022. Mr. Christensen owns 19,551 shares of Insulet stock worth more than $5,211,906 as of November 21st. This net worth estimate does not reflect any other assets that Mr. Christensen may own. Learn More about Bret Christensen's net worth.
How do I contact Bret Christensen?: The corporate mailing address for Mr. Christensen and other Insulet executives is 100 NAGOG PARK, ACTON MA, 01720. Insulet can also be reached via phone at (978) 600-7000 and via email at [email protected]. Learn More on Bret Christensen's contact information.
Has Bret Christensen been buying or selling shares of Insulet?: Bret Christensen has not been actively trading shares of Insulet during the last ninety days. Most recently, Bret Christensen sold 2,900 shares of the business's stock in a transaction on Wednesday, August 24th. The shares were sold at an average price of $264.24, for a transaction totalling $766,296.00. Following the completion of the sale, the executive vice president now directly owns 19,551 shares of the company's stock, valued at $5,166,156.24. Learn More on Bret Christensen's trading history.
Who are Insulet's active insiders?: Insulet's insider roster includes Charles Alpuche (COO), Eric Benjamin (SVP), Luciana Borio (Director), Bret Christensen (EVP), Sally Crawford (Director), John Fallon (Director), Mark Field (SVP and Chief Technology Officer), James Hollingshead (CEO), Dan Manea (SVP), Wayde McMillan (CFO), Shacey Petrovic (CEO), Timothy Scannell (Director), Prem Singh (SVP), and Michael Spears (SVP). Learn More on Insulet's active insiders.
Are insiders buying or selling shares of Insulet?: In the last twelve months, insiders at the medical instruments supplier sold shares 5 times. They sold a total of 25,540 shares worth more than $4,527,624.61. The most recent insider tranaction occured on June, 14th when SVP Mark N Field sold 1,500 shares worth more than $299,940.00. Insiders at Insulet own 0.5% of the company. Learn More about insider trades at Insulet.
Information on this page was last updated on 6/14/2024.

Bret Christensen Insider Trading History at Insulet

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
8/24/2022	Sell	2,900	$264.24	$766,296.00	19,551
8/26/2021	Sell	3,000	$294.13	$882,390.00	16,331
8/12/2020	Sell	5,000	$201.54	$1,007,700.00

Bret Christensen Buying and Selling Activity at Insulet

Insulet Company Overview

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. The company's Omnipod platform includes the Omnipod 5 Automated Insulin Delivery System (Omnipod 5) which includes a proprietary AID algorithm embedded in the Pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless bluetooth communication; Omnipod DASH that features a bluetooth enabled Pod that is controlled by a smartphone-like Personal Diabetes Manager with a color touch screen user interface; and Omnipod GO, a standalone, wearable, insulin delivery system that provides a fixed rate of continuous rapid-acting insulin for 72 hours. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, Australia, and internationally. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.

Today's Range

Now: $266.58

$260.63

$267.05

50 Day Range

MA: $240.09

$227.79

$275.70

2 Week Range

Now: $266.58

$160.19

$279.40

Volume

504,270 shs

Average Volume

606,420 shs

Market Capitalization

$18.70 billion

P/E Ratio

45.65

Dividend Yield

N/A

Beta

1.22

Watch this before it gets removed

From Porter & Company | Ad

If you missed it, my emergency election broadcast is now available - but will be removed soon

Click here to watch it now.